Feline CA199 antibody and antigen (recombinant protein)
Diagnostic anti-Feline CA199 antibodies pairs and antigen for animal health (animal Cat/Feline pancreatic and biliary tract tumors) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-FEL-CA199-Ag01 | Recombinant Feline CA199 protein | 3090 |
GMP-FEL-CA199-Ab01 | Anti-Feline CA199 mouse monoclonal antibody (mAb) | 1953 |
GMP-FEL-CA199-Ab02 | Anti-Feline CA199 mouse monoclonal antibody (mAb) | 1953 |
GMP-FEL-CA199-Ab03 | Anti-Feline CA199 human monoclonal antibody (mAb) | 1953 |
GMP-FEL-CA199-Ab04 | Anti-Feline CA199 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-FEL-CA199-Ag01 |
Product Name | Recombinant Feline CA199 protein |
Target/Biomarker | Feline Carbohydrate antigen 19-9 (IBV - Variant 4/91) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Feline Carbohydrate antigen 19-9 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in IBV - Variant 4/91 level test of animal Cat/Feline with pancreatic and biliary tract tumors. |
Tag | His |
Products description | Recombinant Feline CA199 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-FEL-CA199-Ab01, GMP-FEL-CA199-Ab02 |
Product Name | Anti-Feline CA199 mouse monoclonal antibody (mAb) |
Target/Biomarker | Feline Carbohydrate antigen 19-9 (IBV - Variant 4/91) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Feline Carbohydrate antigen 19-9 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-IBV - Variant 4/91 antibodies in IBV - Variant 4/91 level test of animal Cat/Feline with pancreatic and biliary tract tumors. |
Tag | mFc |
Products description | Anti-Feline CA199 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-IBV - Variant 4/91 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-FEL-CA199-Ab03, GMP-FEL-CA199-Ab04 |
Product Name | Anti-Feline CA199 human monoclonal antibody (mAb) |
Target/Biomarker | Feline Carbohydrate antigen 19-9 (IBV - Variant 4/91) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Feline Carbohydrate antigen 19-9 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-IBV - Variant 4/91 antibodies in IBV - Variant 4/91 level test of animal Cat/Feline with pancreatic and biliary tract tumors. |
Tag | hFc |
Products description | Anti-Feline CA199 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-IBV - Variant 4/91 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Cancer Antigen 199 (CA199) is a glycoprotein biomarker that assumes a pivotal role in feline health, particularly in the sphere of cancer diagnosis and monitoring. This biomarker is associated with several types of cancer in cats, including those affecting the pancreas, gastrointestinal tract, and liver. Structurally, CA199 is classified as a carbohydrate antigen, featuring a protein core with attached carbohydrate molecules. In the context of feline health, CA199 assumes significance as a diagnostic tool for the early detection of cancer. Cancers affecting the pancreas, gastrointestinal tract, or liver can be insidious, often presenting with subtle or nonspecific clinical signs. CA199 blood tests offer a non-invasive and sensitive means of identifying these malignancies, allowing for timely intervention and potentially improving treatment outcomes. CA199 levels in a cat's bloodstream become elevated when cancer cells, particularly those found in pancreatic, gastrointestinal, or hepatic cancers, produce and release this glycoprotein. As a result, CA199 serves as a biomarker that can be readily detected and quantified through blood tests.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.